The study expands on prior research by incorporating a larger more diverse CKD/ESRD population followed over a longer period, and it adjusted for several important confounders, such as kidney transplant status.
Risk for dying from heart attack, stroke higher among those with high blood pressure, diabetes and short sleep.
But no association observed between sleep duration or quality and change in BP drug use
People with obstructive sleep apnea continued to be at higher risk of developing gout after the first year of obstructive sleep apnea diagnosis.
Findings emerged from an analysis of data from 2588 men who participated in the REDUCE trial.
Short sleep duration is associated with a 47% increased risk of proteinuria, a surrogate marker for kidney disease progression.
After 6 months, researchers found a greater decrease in HbA1c levels compared to the control group.
In these patients, systolic blood pressure at night was elevated by an average of 2.9 mm Hg.
Chronic kidney disease found to be 58% more likely to develop in individuals with than without the sleep disorder.
Researchers find both common treatments produce modest BP decreases in sleep apnea patients.
